ANGPT1 as a Prognostic Biomarker in a Large-Scale Pan-cancer Analysis
RNA-seq (gene expression) · human · 13 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 13 samples
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE286446_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1209377 and SRA study SRP556662. Searching any of these in the dataset finder brings you back here.
The grouping that defines any comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Sample titles run AML_1 … AML_13 and carry no group information.
- GSM8727784 AML_1
- GSM8727785 AML_2
- GSM8727786 AML_3
- GSM8727787 AML_4
- GSM8727788 AML_5
- GSM8727789 AML_6
- GSM8727790 AML_7
- GSM8727791 AML_8
- GSM8727792 AML_9
- GSM8727793 AML_10
- GSM8727794 AML_11
- GSM8727795 AML_12
- GSM8727796 AML_13
- GSE287352 Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma 22 samples shares prognostic, biomarker
- GSE295399 Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer 146 samples shares prognostic, biomarker
- GSE267442 Identification of CLIC3 as a novel prognostic biomarker in triple-negative breast cancer via characteristic analysis (RNA-Seq) 16 samples shares prognostic, biomarker
- GSE287956 CAN-Scan: a multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer 69 samples shares prognostic, biomarker
- GSE293444 STAT1 and STAT3 Signaling in Ovarian Cancer: Prognostic Biomarkers and Therapeutic Targets [RNA-seq] 54 samples shares prognostic, biomarker
- GSE302917 TP53 Mutation is a Prognostic Biomarker for Patients with Advanced RAS Wild-Type Colorectal Adenocarcinoma Treated with Cetuximab and Pembrolizumab [dataset 1] 28 samples shares prognostic, biomarker
- GSE305211 Carbonic Anhydrase 12 is a Novel Prognostic Biomarker and Therapeutic Target for High-Risk Follicular Thyroid Cancer 19 samples shares prognostic, biomarker
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples shares prognostic, biomarker
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.